’25 injections, emotional and physical trauma,’ Namita Thapar recalls horrible IVF journey on Shark Tank India Season 2

Shark Tank India Season 2

Shark Tank India Season 2: Vikram Rajput, Sohan Sahu and Chandan Prasad came to present Subhag, Home IUI Kit. They shared a story of an infertile couple in their pitch and impressed the sharks. Pitchers asked for 50 lakhs in the exchange of 1% equity in the company. Sharks seem to be happy to see the product and Namita Thapar felt connected with it.

Shark Tank India Season 2: Namita Thapar recalls her journey

Namita Thapar shared a personal story with the pitchers, “Main jab 28 thi toh maine try Kiya bacche ke liye…2 mahine mein I conceived normal pregnant thi sab kuch theek. Uske baad 3-4 saal I tried aur I couldn’t conceive which is rare. 2 infertility treatments I have gone through aur vo jo 25 injections hote hain har treatment mein vo jo physical emotional trauma hota hai. Those taboos of crossing your legs…paer upar rakho. Matlab sab stupid cheezein aap karte hain aur Mera toh already ek baccha tha toh imagine the trauma un parents ke liye jinke bacche nahi hain. Phir Aisa hua ki do mere attempts fail ho gaye…I gave up I said I am happy with one child aur phir jaise bolte hain miraculously maine naturally conceive Kiya lekin vo jo ek memory thi. 10 saal Tak I didn’t talk about it kyunki vo itna taboo laga mujhe ki I’ll be little less if I talk about it.”

Namita Thapar calls herself ‘Pharma Queen’

Sharks praised Namita Thapar for being vocal about her personal story and sharing it on national television. Anupam Mittal slammed the pitchers for not taking the business seriously as the founder was waiting for investment to get shift in India. Vineeta Singh and Namita Thapar gave offers to them but the pitchers bagged Namita’s offer and Namita called herself ‘Pharma Queen.’

Also Read: Did Shark Tank India judge Aman Gupta wear his watch on palm for boAt marketing? Netizens say “Gajab style hai sir aapka”

Keep watching our YouTube Channel ‘DNP INDIA’. Also, please subscribe and follow us on FACEBOOKINSTAGRAM, and TWITTER

Exit mobile version